Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Formosa Plastics Group (FPG) is a diversified Taiwanese conglomerate that has established a significant presence in the life sciences and healthcare sectors through its specialized subsidiaries and affiliated institutions. The group's healthcare ecosystem includes Formosa Pharmaceuticals, which focuses on clinical-stage drug development in ophthalmology and oncology, and Formosa Biomedical Technology, which specializes in diagnostics, medical devices, and consumer health products. FPG is also closely linked to the Chang Gung Memorial Hospital system, one of the world's largest medical networks, providing a robust infrastructure for clinical research and patient care. Additionally, the group operates in the pharmaceutical manufacturing space through Formosa Laboratories, a prominent producer of active pharmaceutical ingredients (APIs) and a provider of CDMO services. This integrated approach allows FPG to span the entire healthcare value chain from basic research and manufacturing to large-scale clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Formosa Plastics Group.